For research use only. Not for therapeutic Use.
Imeglimin (Cat No.:I004855) is the first of a new class of oral antidiabetic drugs containing tetrahydrotriazine – gliadin; it has been shown to act on liver, muscle and pancreatic beta cells, uniquely targeting the key defect in type 2 diabetes.
| Catalog Number | I004855 |
| CAS Number | 775351-65-0 |
| Synonyms | (4R)-6-N,6-N,4-trimethyl-1,4-dihydro-1,3,5-triazine-2,6-diamine |
| Molecular Formula | C6H13N5 |
| Purity | ≥95% |
| Target | NF-κB |
| Solubility | 10 mM in DMSO |
| Storage | Store at -20C |
| InChI | InChI=1S/C6H13N5/c1-4-8-5(7)10-6(9-4)11(2)3/h4H,1-3H3,(H3,7,8,9,10)/t4-/m0/s1 |
| InChIKey | GFICWFZTBXUVIG-BYPYZUCNSA-N |
| SMILES | NC1=N[C@H](C)NC(N(C)C)=N1 |
